A heating and freezing process known as dual thermal ablation can kill pancreatic cancer cells, according to new research from Binghamton University, State University at New York.
The collaborative study, conducted by researchers from academia and industry and funded by grants from the National Cancer Institute, used pancreatic cancer cells to investigate the effect of heating and freezing on cell death. The research was conducted by Robert Van Buskirk and John Baust, professors of biological sciences and directors at Binghamton University’s Institute of Biomedical Technology, and Kenneth Baumann, a graduate student studying biology.
“How do we solve the problem of pancreatic cancer when it comes to trying to get rid of the tumor, when chemo and radiation just simply doesn’t work?” said Van Buskirk. “The whole idea is, can one come up with a different surgical intervention that’s less invasive and more effective?
“In order to figure that out, you can commercially obtain pancreatic cancer cells and grow them on specialized plasticware,” Van Buskirk said. “The basic question is, are both freezing and heat in combination more effective than freezing or heat alone? If you freeze pancreatic cancer cells like you do in cryoablation, a lot of them die, but some will survive and regrow. If you heat them, they’ll die, but again some will come back. But with dual-thermal ablation, for reasons that we do not yet understand, more die and don’t come back. In fact, over time, cells that survive the initial insult continue to die.”
“What we’ve observed is that we are able to achieve complete cell death using a combination of heating and then freezing at temperatures that alone would not be lethal to kill pancreatic cancer cells,” said Baumann.
Researchers heated and froze cancer cells and looked at the effect, using various technologies to determine the level of cell death, on regrowth as well as which cell stress pathways were activated.
“Using a variety of assays, we are able to determine the initial level of cell death as well as to what extent the surviving population is able to regrow,” Baumann said. “We were also able to determine the specific paths of cell death activated as a result of the dual thermal exposure.”
“When cells are disturbed—which means they are frozen or they see heat—various cell stress pathways are activated,” said Van Buskirk. “The interesting thing about cells, especially cancer cells, is that they will activate pathways to protect themselves. The objective of this line of molecular-based research is to find out which stress pathways are activated in pancreatic cancer cells so that we can better understand why dual-thermal ablation appears to be more effective.”
“Current studies are focused on elucidating which stress pathways specifically cause these cells to die or what is keeping them alive. That way, we can optimize this treatment to be as effective as possible against pancreatic cancer,” Baumann said.
According to Van Buskirk, modulating these stress pathways is the key to making the heating and freezing ablation process more effective. This could lead to the development of a new way to remove cancerous pancreatic tumors.
In addition to the cell molecular research, several members of the study team are working on developing new catheter technologies to deliver this ablative therapy to patients. “If a very thin catheter can be developed to target the tumor, and if we understand how pancreatic cancer responds to ablation at the molecular level, then we may be able to develop a new therapy to approach something that has been completely unapproachable, the targeted killing of a tumor in a very difficult place: the pancreas,” said Van Buskirk.
The Latest on: Pancreatic cancer
- Don't Screen Asymptomatic Adults for Pancreatic Cancer on February 19, 2019 at 11:16 am
Although uncommon overall, pancreatic cancer is a deadly disease -- ranking as the third most common cause of cancer death in the United States. Sadly, most cases of pancreatic cancer aren't found ear... […]
- Karl Lagerfeld Reportedly Died In Paris Hospital After Secret Battle With Pancreatic Cancer on February 19, 2019 at 8:20 am
As we reported early Tuesday morning, Karl Lagerfeld has died at 85. While there were minimal details out at the time, it’s now being said the creative director and designer passed away in a ... […]
- Report: Karl Lagerfeld had been diagnosed with pancreatic cancer on February 19, 2019 at 8:09 am
The fashion world is mourning the loss of an icon this morning. It was announced on Tuesday morning that the prolific designer Karl Lagerfeld had passed away at the age of 85 in Paris. The German-born ... […]
- Ginsburg Returning to Supreme Court Bench After Cancer Surgery on February 19, 2019 at 6:42 am
She has already survived bouts with colon and pancreatic cancer. The court has an abbreviated schedule this week, with only two 60-minute arguments. In the Tuesday case, the issue is whether federal a... […]
- How to Treat Pancreatic Cancer on February 18, 2019 at 12:10 pm
There is no way to sugarcoat the fact that pancreatic cancer is very difficult to treat. Only about 20 to 30 percent of cases are found early enough to treat surgically, before the cancer has ... […]
- Using tree bark to treat pancreatic cancer on February 18, 2019 at 9:52 am
BUFFALO -- (02/18/2019) -- Pancreatic cancer is one of the most difficult to treat and few patients survive past five years. But researchers are finding new hope in an ancient remedy. Michael Gilkerso... […]
- Health Beat: Chinese tree bark treats pancreatic cancer on February 13, 2019 at 1:47 pm
BUFFALO - Michael Gilkerson doesn't miss a day on his treadmill. He said it gives him strength and motivation after being diagnosed with pancreatic cancer more than two years ago. "I've never told my ... […]
- USPSTF Still Recommends Against Pancreatic Cancer Screening on February 13, 2019 at 11:18 am
(HealthDay News) -- The U.S. Preventive Services Task Force (USPSTF) recommends against screening for pancreatic cancer in asymptomatic adults. These findings form the basis of a draft recommendation ... […]
- Drug made from Chinese tree bark offers hope for pancreatic cancer patients on February 11, 2019 at 3:32 pm
BUFFALO, N.Y. - Researchers are finding new hope in an ancient remedy to treat pancreatic cancer. Pancreatic cancer is one of the toughest cancers to treat. Only 6 to 8 percent of patients survive fiv... […]
- A Patient's Guide to Pancreatic Cancer on February 11, 2019 at 12:07 pm
According to the American Cancer Society, pancreatic cancer accounts for about 3 percent of all cancers in the U.S. and about 7 percent of all cancer deaths. In 2019, the ACS estimates: About ... […]
via Google News and Bing News